Hydroxylase-dependent regulation of the NF-κb pathway

Biological Chemistry

Volumn 394, Issue 4, 2013, Pages 479-493

  Scholz, Carsten C ^a   Taylor, Cormac T ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Hydroxylase; Hypoxia inducible factor (HIF); NF B

Indexed keywords

ASPARAGINE; CITRIC ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOCHROME C OXIDASE; DEFEROXAMINE; FUMARATE HYDRATASE; FUMARIC ACID; HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MICRORNA; OXALOACETIC ACID; OXYGENASE; REACTIVE OXYGEN METABOLITE; SUCCINIC ACID;

ALPHA CHAIN; ANGIOGENESIS; APOPTOSIS; DECARBOXYLATION; DNA REPAIR; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLUCOSE METABOLISM; HYDROXYLATION; INFLAMMATION; INHIBITION KINETICS; INTESTINE MUCOSA; METASTASIS; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGENATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SEPSIS; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; HUMANS; MIXED FUNCTION OXYGENASES; MODELS, BIOLOGICAL; NF-KAPPA B; OXYGEN; SIGNAL TRANSDUCTION;

EID: 84879415483     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0338     Document Type: Review

References (124)

1. Adluri, R.S., Thirunavukkarasu, M., Dunna, N.R., Zhan, L., Oriowo, B., Takeda, K., Sanchez, J.A., Otani, H., Maulik, G., Fong, G.H., et al. (2011). Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1alpha transcription factor and its target genes in mice. Antioxid Redox Signal 15, 1789-1797.
2. Appelhoff, R.J., Tian, Y.M., Raval, R.R., Turley, H., Harris, A.L., Pugh, C.W., Ratcliffe, P.J., and Gleadle, J.M. (2004). Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458-38465.
3. Aragones, J., Schneider, M., Van Geyte, K., Fraisl, P., Dresselaers, T., Mazzone, M., Dirkx, R., Zacchigna, S., Lemieux, H., Jeoung, N.H., et al. (2008). Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40, 170-180.
4. Barrett, T.D., Palomino, H.L., Brondstetter, T.I., Kanelakis, K.C., Wu, X., Haug, P.V., Yan, W., Young, A., Hua, H., Hart, J.C., et al. (2011). Pharmacological characterization of 1-(5-chloro-6- (trifluoromethoxy)-1H- benzoimidazol-2-yl)-1H-pyrazole-4-carb oxylic acid (JNJ-42041935), a potent and selective hypoxiainducible factor prolyl hydroxylase inhibitor. Mol. Pharmacol. 79, 910-920.
5. Berchner-Pfannschmidt, U., Yamac, H., Trinidad, B., and Fandrey, J. (2007). Nitric oxide modulates oxygen sensing by hypoxiainducible factor 1-dependent induction of prolyl hydroxylase 2. J. Biol. Chem. 282, 1788-1796.
6. Berchner-Pfannschmidt, U., Tug, S., Trinidad, B., Oehme, F., Yamac, H., Wotzlaw, C., Flamme, I., and Fandrey, J. (2008). Nuclear oxygen sensing: induction of endogenous prolylhydroxylase 2 activity by hypoxia and nitric oxide. J. Biol. Chem. 283, 31745-31753.
7. Berchner-Pfannschmidt, U., Tug, S., Kirsch, M., and Fandrey, J. (2010). Oxygen-sensing under the influence of nitric oxide. Cell Signal. 22, 349-356.
8. Bergeron, M., Gidday, J.M., Yu, A.Y., Semenza, G.L., Ferriero, D.M., and Sharp, F.R. (2000). Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann. Neurol. 48, 285-296.
9. Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D., and Pouyssegur, J. (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. 22, 4082-4090.
10. Bishop, T., Gallagher, D., Pascual, A., Lygate, C.A., de Bono, J.P., Nicholls, L.G., Ortega-Saenz, P., Oster, H., Wijeyekoon, B., Sutherland, A.I., et al. (2008). Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice. Mol. Cell Biol. 28, 3386-3400.
11. Bruick, R.K. and McKnight, S.L. (2001). A conserved family of prolyl- 4-hydroxylases that modify HIF. Science 294, 1337-1340.
12. Brunelle, J.K., Bell, E.L., Quesada, N.M., Vercauteren, K., Tiranti, V., Zeviani, M., Scarpulla, R.C., and Chandel, N.S. (2005). Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1, 409-414.
13. Chan, D.A., Sutphin, P.D., Denko, N.C., and Giaccia, A.J. (2002). Role of prolyl hydroxylation in oncogenically stabilized hypoxiainducible factor-1alpha. J. Biol. Chem. 277, 40112-40117.
14. Chan, D.A., Kawahara, T.L., Sutphin, P.D., Chang, H.Y., Chi, J.T., and Giaccia, A.J. (2009). Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell 15, 527-538.
15. Chandel, N.S., McClintock, D.S., Feliciano, C.E., Wood, T.M., Melendez, J.A., Rodriguez, A.M., and Schumacker, P.T. (2000). Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 275, 25130-25138.
16. Chowdhury, R., Flashman, E., Mecinovic, J., Kramer, H.B., Kessler, B.M., Frapart, Y.M., Boucher, J.L., Clifton, I.J., McDonough, M.A., and Schofield, C.J. (2011). Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1). J. Mol. Biol. 410, 268-279.
17. Chua, Y.L., Dufour, E., Dassa, E.P., Rustin, P., Jacobs, H.T., Taylor, C.T., and Hagen, T. (2010). Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J. Biol. Chem. 285, 31277-31284.
18. Cockman, M.E., Lancaster, D.E., Stolze, I.P., Hewitson, K.S., McDonough, M.A., Coleman, M.L., Coles, C.H., Yu, X., Hay, R.T., Ley, S.C., et al. (2006). Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxiainducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl. Acad. Sci. USA 103, 14767-14772.
19. Cockman, M.E., Webb, J.D., Kramer, H.B., Kessler, B.M., and Ratcliffe, P.J. (2009). Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins. Mol. Cell Proteomics 8, 535-546.
20. Colgan, S.P., and Taylor, C.T. (2010). Hypoxia: an alarm signal during intestinal inflammation. Nat. Rev. Gastroenterol Hepatol 7, 281-287.
21. Cummins, E.P. and Taylor, C.T. (2005). Hypoxia-responsive transcription factors. Pflüger's Arch 450, 363-371.
22. Cummins, E.P., Berra, E., Comerford, K.M., Ginouves, A., Fitzgerald, K.T., Seeballuck, F., Godson, C., Nielsen, J.E., Moynagh, P., Pouyssegur, J., et al. (2006). Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc. Natl. Acad. Sci. USA 103, 18154-18159.
23. Cummins, E.P., Comerford, K.M., Scholz, C., Bruning, U., and Taylor, C.T. (2007). Hypoxic regulation of NF-κB signaling. Method Enzymol. 435, 479-492.
24. Cummins, E.P., Seeballuck, F., Keely, S.J., Mangan, N.E., Callanan, J.J., Fallon, P.G., and Taylor, C.T. (2008). The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134, 156-165.
25. Dendorfer, A., Heidbreder, M., Hellwig-Burgel, T., Johren, O., Qadri, F., and Dominiak, P. (2005). Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals. Free Radic. Biol. Med. 38, 117-124.
26. Devries, I.L., Hampton-Smith, R.J., Mulvihill, M.M., Alverdi, V., Peet, D.J., and Komives, E.A. (2010). Consequences of IkappaB alpha hydroxylation by the factor inhibiting HIF (FIH). FEBS Lett. 584, 4725-4730.
27. Doege, K., Heine, S., Jensen, I., Jelkmann, W., and Metzen, E. (2005). Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 106, 2311-2317.
28. Egan, L.J. and Toruner, M. (2006). NF-κB signaling: pros and cons of altering NF-kappaB as a therapeutic approach. Ann. NY Acad. Sci. 1072, 114-122.
29. Elvidge, G.P., Glenny, L., Appelhoff, R.J., Ratcliffe, P.J., Ragoussis, J., and Gleadle, J.M. (2006). Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1α , HIF-2α , and other pathways. J. Biol. Chem. 281, 15215-15226.
30. Ema, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y., and Fujii-Kuriyama, Y. (1997). A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. USA 94, 4273-4278.
31. Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
32. Fitzpatrick, S.F., Tambuwala, M.M., Bruning, U., Schaible, B., Scholz, C.C., Byrne, A., O'Connor, A., Gallagher, W.M., Lenihan, C.R., Garvey, J.F., et al. (2011). An intact canonical NF-κB pathway is required for inflammatory gene expression in response to hypoxia. J. Immunol. 186, 1091-1096.
33. Flamme, I., Frohlich, T., von Reutern, M., Kappel, A., Damert, A., and Risau, W. (1997). HRF, a putative basic helix-loop-helix- PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels. Mech. Dev. 63, 51-60.
34. Fraisl, P., Aragones, J., and Carmeliet, P. (2009). Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat. Rev. Drug Discov. 8, 139-152.
35. Fu, J. and Taubman, M.B. (2010). Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-κB-dependent pathway. J. Biol. Chem. 285, 8927-8935.
36. Gerald, D., Berra, E., Frapart, Y.M., Chan, D.A., Giaccia, A.J., Mansuy, D., Pouyssegur, J., Yaniv, M., and Mechta-Grigoriou, F. (2004). JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118, 781-794.
37. Gilmore, T.D. and Herscovitch, M. (2006). Inhibitors of NF-κB signaling: 785 and counting. Oncogene 25, 6887-6899.
38. Ginouves, A., Ilc, K., Macias, N., Pouyssegur, J., and Berra, E. (2008). PHDs overactivation during chronic hypoxia " desensitizes " HIFα and protects cells from necrosis. Proc. Natl. Acad. Sci. USA 105, 4745-4750.
39. Glocker, E.O., Kotlarz, D., Klein, C., Shah, N., and Grimbacher, B. (2011). IL-10 and IL-10 receptor defects in humans. Ann. NY Acad. Sci. 1246, 102-107.
40. Gu, Y.Z., Moran, S.M., Hogenesch, J.B., Wartman, L., and Bradfield, C.A. (1998). Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α. Gene. Express. 7, 205-213.
41. Guzy, R.D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K.D., Simon, M.C., Hammerling, U., and Schumacker, P.T. (2005). Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401-408.
42. Hagen, T., Taylor, C.T., Lam, F., and Moncada, S. (2003). Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α . Science 302, 1975-1978.
43. Hams, E., Saunders, S.P., Cummins, E.P., O'Connor, A., Tambuwala, M.T., Gallagher, W.M., Byrne, A., Campos-Torres, A., Moynagh, P.M., Jobin, C., et al. (2011). The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells. Shock 36, 295-302.
44. Hara, S., Hamada, J., Kobayashi, C., Kondo, Y., and Imura, N. (2001). Expression and characterization of hypoxia-inducible factor (HIF)-3α in human kidney: suppression of HIF-mediated gene expression by HIF-3α. Biochem. Biophys. Res. Comm. 287, 808-813.
45. Hauser, C.J., Locke, R.R., Kao, H.W., Patterson, J., and Zipser, R.D. (1988). Visceral surface oxygen tension in experimental colitis in the rabbit. J. Lab. Clin. Med. 112, 68-71.
46. Henze, A.T. and Acker, T. (2010). Feedback regulators of hypoxiainducible factors and their role in cancer biology. Cell Cycle 9, 2749-2763.
47. Henze, A.T., Riedel, J., Diem, T., Wenner, J., Flamme, I., Pouyseggur, J., Plate, K.H., and Acker, T. (2010). Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res. 7 0, 357-3 66.
48. Hewitson, K.S., McNeill, L.A., Riordan, M.V., Tian, Y.M., Bullock, A.N., Welford, R.W., Elkins, J.M., Oldham, N.J., Bhattacharya, S., Gleadle, J.M., et al. (2002). Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351-26355.
49. Hewitson, K.S., Lienard, B.M., McDonough, M.A., Clifton, I.J., Butler, D., Soares, A.S., Oldham, N.J., McNeill, L.A., and Schofield, C.J. (2007). Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. J. Biol. Chem. 282, 3293-3301.
50. Hirsila, M., Koivunen, P., Xu, L., Seeley, T., Kivirikko, K.I., and Myllyharju, J. (2005). Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J. 19, 1308-1310.
51. Ho, J.J., Man, H.S., and Marsden, P.A. (2012). Nitric oxide signaling in hypoxia. J. Mol. Med. 90, 217-231.
52. Hogenesch, J.B., Chan, W.K., Jackiw, V.H., Brown, R.C., Gu, Y.Z., Pray-Grant, M., Perdew, G.H., and Bradfield, C.A. (1997). Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J. Biol. Chem. 272, 8581-8593.
53. Isaacs, J.S., Jung, Y.J., Mole, D.R., Lee, S., Torres-Cabala, C., Chung, Y.L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143-153.
54. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J.M., Lane, W.S., and Kaelin, W.G., Jr. (2001). HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O 2 sensing. Science 292, 464-468.
55. Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J., Gaskell, S.J., Kriegsheim, A., Hebestreit, H.F., Mukherji, M., Schofield, C.J., et al. (2001). Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O 2 -regulated prolyl hydroxylation. Science 292, 468-472.
56. Kaelin, W.G. (2005). Proline hydroxylation and gene expression. Ann. Rev. Biochem. 74, 115-128.
57. Kaelin, W.G., Jr. and Ratcliffe, P.J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393-402.
58. Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D'Acquisto, F., Addeo, R., Makuuchi, M., and Esumi, H. (2000). Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95, 189-197.
59. Kivirikko, K.I., Myllyla, R., and Pihlajaniemi, T. (1989). Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. FASEB J. 3, 1609-1617.
60. Knowles, H.J., Raval, R.R., Harris, A.L., and Ratcliffe, P.J. (2003). Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63, 1764-1768.
61. Knowles, H.J., Tian, Y.M., Mole, D.R., and Harris, A.L. (2004). Novel mechanism of action for hydralazine: induction of hypoxiainducible factor-1α , vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Circ. Res. 95, 162-169.
62. Koivunen, P., Hirsila, M., Remes, A.M., Hassinen, I.E., Kivirikko, K.I., and Myllyharju, J. (2007). Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J. Biol. Chem. 282, 4524-4532.
63. Koivunen, P., Lee, S., Duncan, C.G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J.A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012). Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483, 484-488.
64. Koong, A.C., Chen, E.Y., and Giaccia, A.J. (1994). Hypoxia causes the activation of nuclear factor κB through the phosphorylation of I kappa Bα on tyrosine residues. Cancer Res. 54, 1425-1430.
65. Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L., and Bruick, R.K. (2002). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
66. Lee, D.F. and Hung, M.C. (2008). Advances in targeting IKK and IKK-related kinases for cancer therapy. Clin. Cancer Res. 14, 5656-5662.
67. Lipscomb, E.A., Sarmiere, P.D., and Freeman, R.S. (2001). SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J. Biol. Chem. 276, 5085-5092.
68. Liu, C.J., Tsai, M.M., Hang, P.S., Kao, S.Y., Liu, T.Y., Wu, K.G., Chiou, S.H., Lin, S.C., and Changi, K.W. (2010). miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res. 70, 1635-1644.
69. MacKenzie, E.D., Selak, M.A., Tennant, D.A., Payne, L.J., Crosby, S., Frederiksen, C.M., Watson, D.G., and Gottlieb, E. (2007). Cell-permeating α-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol. Cell Biol. 27, 3282-3289.
70. Madden, S.L., Galella, E.A., Riley, D., Bertelsen, A.H., and Beaudry, G.A. (1996). Induction of cell growth regulatory genes by p53. Cancer Res. 56, 5384-5390.
71. Mahon, P.C., Hirota, K., and Semenza, G.L. (2001). FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686.
72. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A., and Poellinger, L. (2001). Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550-554.
73. Manalo, D.J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B.D., Ye, S.Q., Garcia, J.G., and Semenza, G.L. (2005). Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105, 659-669.
74. Mansfield, K.D., Guzy, R.D., Pan, Y., Young, R.M., Cash, T.P., Schumacker, P.T., and Simon, M.C. (2005). Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-α activation. Cell Metab. 1, 393-399.
75. Masson, N., Singleton, R.S., Sekirnik, R., Trudgian, D.C., Ambrose, L.J., Miranda, M.X., Tian, Y.M., Kessler, B.M., Schofield, C.J., and Ratcliffe, P.J. (2012). The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity. EMBO Rep. 13, 251-257.
76. Mateo, J., Garcia-Lecea, M., Cadenas, S., Hernandez, C., and Moncada, S. (2003). Regulation of hypoxia-inducible factor-1α by nitric oxide through mitochondria-dependent and -independent pathways. Biochem. J. 376, 537-544.
77. Matsui, H., Ihara, Y., Fujio, Y., Kunisada, K., Akira, S., Kishimoto, T., and Yamauchi-Takihara, K. (1999). Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-κB and NF-IL6 in cardiac myocytes. Cardiovasc. Res. 42, 104-112.
78. Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R., and Ratcliffe, P.J. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
79. Maynard, M.A., Qi, H., Chung, J., Lee, E.H., Kondo, Y., Hara, S., Conaway, R.C., Conaway, J.W., and Ohh, M. (2003). Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 278, 11032-11040.
80. Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.M., Lanahan, A.A., Pollard, P., Ruiz de Almodovar, C., et al. (2009). Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839-851.
81. McNeill, L.A., Hewitson, K.S., Claridge, T.D., Seibel, J.F., Horsfall, L.E., and Schofield, C.J. (2002). Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the β-carbon of asparagine-803. Biochem. J. 367, 571-575.
82. Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., and Brune, B. (2003). Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases. Mol. Biol. Cell 14, 3470-3481.
83. Minamishima, Y.A., Moslehi, J., Bardeesy, N., Cullen, D., Bronson, R.T., and Kaelin, W.G., Jr. (2008). Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111, 3236-3244.
84. Murdoch, C., Muthana, M., and Lewis, C.E. (2005). Hypoxia regulates macrophage functions in inflammation. J. Immunol. 175, 6257-6263.
85. Nangaku, M., Izuhara, Y., Takizawa, S., Yamashita, T., Fujii-Kuriyama, Y., Ohneda, O., Yamamoto, M., van Ypersele de Strihou, C., Hirayama, N., and Miyata, T. (2007). A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. Arterioscler. Thromb. Vasc. Biol. 27, 2548-2554.
86. Niecknig, H., Tug, S., Reyes, B.D., Kirsch, M., Fandrey, J., and Berchner-Pfannschmidt, U. (2012). Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia. Free Radic. Res. 46, 705-717.
87. Nytko, K.J., Maeda, N., Schlafli, P., Spielmann, P., Wenger, R.H., and Stiehl, D.P. (2011). Vitamin C is dispensable for oxygen sensing in vivo. Blood 117, 5485-5493.
88. Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., Huang, L.E., Pavletich, N., Chau, V., and Kaelin, W.G. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423-427.
89. Oliver, K.M., Garvey, J.F., Ng, C.T., Veale, D.J., Fearon, U., Cummins, E.P., and Taylor, C.T. (2009). Hypoxia activates NF-κBdependent gene expression through the canonical signaling pathway. Antioxid. Redox Signal 11, 2057-2064.
90. Page, E.L., Chan, D.A., Giaccia, A.J., Levine, M., and Richard, D.E. (2008). Hypoxia-inducible factor-1α stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol. Biol. Cell 19, 86-94.
91. Pan, Y., Mansfield, K.D., Bertozzi, C.C., Rudenko, V., Chan, D.A., Giaccia, A.J., and Simon, M.C. (2007). Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol. Cell Biol. 27, 912-925.
92. Park, Y.K., Ahn, D.R., Oh, M., Lee, T., Yang, E.G., Son, M., and Park, H. (2008). Nitric oxide donor, (+ /-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1α by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation. Mol. Pharmacol. 74, 236-245.
93. Pollard, P.J., Briere, J.J., Alam, N.A., Barwell, J., Barclay, E., Wortham, N.C., Hunt, T., Mitchell, M., Olpin, S., Moat, S.J., et al. (2005). Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14, 2231-2239.
94. Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A.S., Nizet, V., Johnson, R.S., Haddad, G.G., and Karin, M. (2008). NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α . Nature 453, 807-811.
95. Robinson, A., Keely, S., Karhausen, J., Gerich, M.E., Furuta, G.T., and Colgan, S.P. (2008). Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134, 145-155.
96. Rosenberger, C., Rosen, S., Shina, A., Frei, U., Eckardt, K.U., Flippin, L.A., Arend, M., Klaus, S.J., and Heyman, S.N. (2008). Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney. Nephrol. Dial. Transplant 23, 3472-3478.
97. Schodel, J., Oikonomopoulos, S., Ragoussis, J., Pugh, C.W., Ratcliffe, P.J., and Mole, D.R. (2011). High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117, e207-217.
98. Schofield, C.J. and Ratcliffe, P.J. (2004). Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5, 343-354.
99. Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B., and Gottlieb, E. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7, 77-85.
100. Semenza, G.L. (2010). Oxygen homeostasis. Wiley interdisciplinary reviews. Systems Biol. Med. 2, 336-361.
101. Semenza, G.L. (2012). Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408.
102. Semenza, G.L. and Wang, G.L. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12, 5447-5454.
103. Seth, P., Krop, I., Porter, D., and Polyak, K. (2002). Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Oncogene 21, 836-843.
104. Shin, D.H., Li, S.H., Yang, S.W., Lee, B.L., Lee, M.K., and Park, J.W. (2009). Inhibitor of nuclear factor-κB α derepresses hypoxiainducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxiainducible factor 1α . FEBS J. 276, 3470-3480.
105. Stiehl, D.P., Wirthner, R., Koditz, J., Spielmann, P., Camenisch, G., and Wenger, R.H. (2006). Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J. Biol. Chem. 281, 23482-23491.
106. Takeda, K., Ho, V.C., Takeda, H., Duan, L.J., Nagy, A., and Fong, G.H. (2006). Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell Biol. 26, 8336-8346.
107. Takeda, K., Aguila, H.L., Parikh, N.S., Li, X., Lamothe, K., Duan, L.J., Takeda, H., Lee, F.S., and Fong, G.H. (2008). Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111, 3229-3235.
108. Takeda, K., Ichiki, T., Narabayashi, E., Inanaga, K., Miyazaki, R., Hashimoto, T., Matsuura, H., Ikeda, J., Miyata, T., and Sunagawa, K. (2009). Inhibition of prolyl hydroxylase domaincontaining protein suppressed lipopolysaccharide-induced TNF-α expression. Arterioscler. Thromb. Vasc. Biol. 29, 2132-2137.
109. Takeda, Y., Costa, S., Delamarre, E., Roncal, C., Leite de Oliveira, R., Squadrito, M.L., Finisguerra, V., Deschoemaeker, S., Bruyere, F., Wenes, M., et al. (2011). Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479, 122-126.
110. Taylor, C.T. (2008). Interdependent roles for hypoxia inducible factor and nuclear factor-κB in hypoxic inflammation. J. Physiol. 586, 4055-4059.
111. Taylor, C.T. and McElwain, J.C. (2010). Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans. Physiology 25, 272-279.
112. Taylor, C.T., Dzus, A.L., and Colgan, S.P. (1998). Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor α. Gastroenterology 114, 657-668.
113. Tian, H., McKnight, S.L., and Russell, D.W. (1997). Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11, 72-82.
114. Tian, Y.M., Yeoh, K.K., Lee, M.K., Eriksson, T., Kessler, B.M., Kramer, H.B., Edelmann, M.J., Willam, C., Pugh, C.W., Schofield, C.J., et al. (2011). Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. J. Biol. Chem. 286, 13041-13051.
115. Tug, S., Delos Reyes, B., Fandrey, J., and Berchner-Pfannschmidt, U. (2009). Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors. Biochem. Biophys. Res. Commun. 384, 519-523.
116. Wang, G.L. and Semenza, G.L. (1995). Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237.
117. Wang, G.L., Jiang, B.H., Rue, E.A., and Semenza, G.L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92, 5510-5514.
118. Wax, S.D., Rosenfield, C.L., and Taubman, M.B. (1994). Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J. Biol. Chem. 269, 13041-13047.
119. Wilkins, S.E., Karttunen, S., Hampton-Smith, R.J., Murchland, I., Chapman-Smith, A., and Peet, D.J. (2012). Factor inhibiting HIF (FIH) recognises distinct molecular features within hypoxia inducible factor (HIF)-α versus ankyrin repeat substrates. J. Biol. Chem. 287, 8769-8781.
120. Winning, S., Splettstoesser, F., Fandrey, J., and Frede, S. (2010). Acute hypoxia induces HIF-independent monocyte adhesion to endothelial cells through increased intercellular adhesion molecule-1 expression: the role of hypoxic inhibition of prolyl hydroxylase activity for the induction of NF-κB. J. Immunol. 185, 1786-1793.
121. Xue, J., Li, X., Jiao, S., Wei, Y., Wu, G., and Fang, J. (2010). Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKβ independent of hydroxylase activity. Gastroenterology 138, 606-615.
122. Yu, F., White, S.B., Zhao, Q., and Lee, F.S. (2001). HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98, 9630-9635.
123. Zampetaki, A., Mitsialis, S.A., Pfeilschifter, J., and Kourembanas, S. (2004). Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-κB: the prominent role of p42/ p44 and PI3 kinase pathways. FASEB J. 18, 1090-1092.
124. Zhang, N., Fu, Z., Linke, S., Chicher, J., Gorman, J.J., Visk, D., Haddad, G.G., Poellinger, L., Peet, D.J., Powell, F., et al. (2010). The asparaginyl hydroxylase factor inhibiting HIF-1α is an essential regulator of metabolism. Cell Metab. 11, 364-378.